medigraphic.com
ISSN 1405-1710 (Print)

2006, Number 1

<< Back Next >>

Rev Cent Dermatol Pascua 2006; 15 (1)

Xeroderma pigmentosum in its variant form: A case report

Rodríguez M, Torres S, Denis-Rodríguez E

Language: Spanish
References: 10
Page: 16-18
PDF size: 115.78 Kb.


ABSTRACT

We present a 51-year-old female patient with long-standing photodamage, actinic keratoses and squamous cell carcinomas, diagnosed clinically as xeroderma pigmentosum variant.


REFERENCES

  1. Lambert WC. Xeroderma pigmentosum. Dermatol Clin 1995; 13(1): 169-209.

  2. Tsao H. Genetics of non-melanoma skin cancer. Arch Dermatol 2001; 137(11): 1486-1492.

  3. Nijsten T. A patient with xeroderma pigmentosum treated with imiquimod 5% cream. J Am Acad Dermatol 2005; 52(1): 170-1.

  4. Ohto T. Life-threatening vocal cord paralysis in a patient with group A xeroderma pigmentosum. Pediatr Neurol 2004; 30(3): 222-4.

  5. Bellus G. Xeroderma pigmentosum with normal DNA repair rates. OMIM # 278750, John Hopkins University, 2001. www.ncbl.nih.gov/entrez/dispomim.cgi?id:278750.

  6. Johnson RE. hRAD30 mutations in the variant form of Xeroderma pigmentosum. Science 1999; 285(5425): 263-5.

  7. Gratcheu A. Molecular genetics of xeroderma pigmentosum variant. Exp Dermatol 2003; 12(5): 529-36.

  8. Itoh T. A simple method for diagnosing xeroderma pigmentosum variant. J Invest Dermatol 1996; 107(3): 349-53.

  9. Hamouda B. Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in xeroderma pigmentosum. J Am Acad Dermatol 2001; 44(6): 1054.

  10. Di Giovanna JJ. Retinoid chemoprevention in the high risk patient. J Am Acad Dermatol 1998; 39(2 pt 3): 582-5.




2020     |     www.medigraphic.com